John A Ornell's most recent trade in Bruker Corp was a trade of 5,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on May 13, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Bruker Corp | John A. Ornell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 May 2025 | 5,000 | 0 | - | - | Stock Option (right to buy) | |
Bruker Corp | John A. Ornell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.15 per share. | 13 May 2025 | 5,000 | 31,445 (0%) | 0% | 18.2 | 90,750 | Common Stock |
Bruker Corp | John A. Ornell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2025 | 3,298 | 26,445 (0%) | 0% | 0 | Common Stock | |
Bruker Corp | Ornell John A. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 2,377 | 23,147 (0%) | 0% | 0 | Common Stock | |
Bruker Corp | John A. Ornell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 1,970 | 20,770 (0%) | 0% | 0 | Common Stock | |
Bruker Corp | John A. Ornell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2022 | 1,841 | 18,800 (0%) | 0% | 0 | Common Stock | |
Bruker Corp | John A. Ornell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2021 | 2,302 | 16,959 (0%) | 0% | 0 | Common Stock |